- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
89 Alzheimer's Disease Trials near Boston, MA
Power is an online platform that helps thousands of Alzheimer's Disease patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerDonanemab for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
2996 Participants Needed
Donanemab for Early Alzheimer's Disease
Trial Details
Key Eligibility Criteria
1736 Participants Needed
Reducing Antibiotic Use for Dementia
Trial Details
Key Eligibility Criteria
750 Participants Needed
64Cu-FBP8 PET Scan for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
30 Participants Needed
Baricitinib for Alzheimer's & ALS
Trial Details
Key Eligibility Criteria
20 Participants Needed
Levetiracetam for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
85 Participants Needed
ONO-2020 for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
240 Participants Needed
Polypill for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
103 Participants Needed
CT1812 for Early Alzheimer's Disease
Trial Details
Key Eligibility Criteria
540 Participants Needed
Diagnostic Test for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
57 Participants Needed
LY3954068 for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
32 Participants Needed
Noninvasive Brain Stimulation for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
204 Participants Needed
Mindfulness for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
100 Participants Needed
Gamma-Music Therapy for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
60 Participants Needed
Closed-Loop Neuromodulation for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
70 Participants Needed
GENUS Stimulation to Prevent Alzheimer's Disease
Trial Details
Key Eligibility Criteria
200 Participants Needed
Non-invasive Brain Stimulation for Dementia
Trial Details
Key Eligibility Criteria
144 Participants Needed
Gamma Light and Sound Therapy for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
50 Participants Needed
TMS for Apathy in Alzheimer's Disease
Trial Details
Key Eligibility Criteria
20 Participants Needed
Light and Sound Stimulation for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
15 Participants Needed
Why Other Patients Applied
"I have been on standard Alzheimer's medication for a few years but know this treatment only works to delay my cognitive deterioration, not improve it. I've been doing research, which brought me here, to consider some of the latest research drugs. While I know that there's no guarantee that a clinical trial improves my condition, I'd like to give one a try and help further the research for all."
"I have a very strong family history of Alzheimer’s, with my maternal grandmother, mother, uncle, and sister having the disease. My APOE status is 2/4. My memory is going, although 6 months ago I tested decently on some cognitive tests. I'd like to help myself by getting ahead of my condition and help others in a similar situation by participating in medical research."
"I watched my mother suffer through years of Alzheimer's Disease and I want to help advance the science for treating AD. I don't want anyone else to have go through what our family went through."
"I watched my mother die from Parkinson’s. At the time of her death, she weighed 85 pounds and could not move any muscles voluntarily except her eyelids. I would like to participate in a trial to help find a better treatment for PD than what is currently available. It is a devastating illness. It breaks my heart that other families will have to go through this."
"I'm so used to losing things, forgetting things, making up to acronyms to remember things only to remember the acromym but not what the letters stand for... I enter a new room to look for an item, only to forget what I was looking for. I've discussed the existing treatments with my neurologist and she's on board with my joining a clinical trial."
Brain Stimulation for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
80 Participants Needed
Foralumab for Mild Cognitive Impairment
Trial Details
Key Eligibility Criteria
16 Participants Needed
Transcranial Magnetic Stimulation for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
30 Participants Needed
Nudge Intervention for Dementia
Trial Details
Key Eligibility Criteria
360 Participants Needed
Dementia Care Training for Dementia
Trial Details
Key Eligibility Criteria
120 Participants Needed
Palliative Care Program for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
474 Participants Needed
Transcranial Photobiomodulation for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
125 Participants Needed
ACI-24.060 for Alzheimer's Disease and Down Syndrome
Trial Details
Key Eligibility Criteria
140 Participants Needed
BIIB080 for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
416 Participants Needed
JNJ-63733657 for Alzheimer's Disease
Trial Details
Key Eligibility Criteria
523 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Alzheimer's Disease clinical trials in Boston, MA pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Alzheimer's Disease clinical trials in Boston, MA work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Alzheimer's Disease trials in Boston, MA 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Boston, MA for Alzheimer's Disease is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Boston, MA several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Alzheimer's Disease medical study in Boston, MA?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Alzheimer's Disease clinical trials in Boston, MA?
Most recently, we added KarXT + KarX-EC for Alzheimer's Disease, KarXT + KarX-EC for Alzheimer's Disease and KarXT + KarX-EC for Alzheimer's Disease to the Power online platform.